Susanne Schaffert, Ph.D., has been President of Novartis Oncology since January 1, 2019. She is a member of the Executive Committee of Novartis.
Ms. Schaffert was appointed Chairperson and President of Advanced Accelerator Applications when it was acquired by Novartis in January 2018. She joined Novartis more than 20 years ago and served as General Manager of Europe for Novartis Oncology from 2012 to 2018. Prior to that, she was Global Head of Investor Relations for Novartis from 2010 to 2012. She has also held other leadership positions during her career at Novartis, including Global Franchise Head for Immunology and Infectious Diseases from 2009 to 2010, General Manager of Northern and Central Europe for Novartis Oncology from 2007 to 2009, and General Manager of Germany for Novartis Oncology from 2004 to 2007.
Ms. Schaffert holds a doctorate in organic chemistry from the University of Erlangen in Germany. She serves on the boards of Novartis AG Germany and the European Federation of Pharmaceutical Industries and Associations (EFPIA) in Belgium. From 2015 to 2018, she represented Novartis on the board of GlaxoSmithKline Consumer Healthcare Holdings Ltd.